Skip to content

Clinical study on the improvement of post-stroke cognitive impairment by inducing gamma oscillations and enhancing brain network connectivity through 40Hz acousto-optic stimulation

Clinical study on the improvement of post-stroke cognitive impairment by inducing gamma oscillations and enhancing brain network connectivity through 40Hz acousto-optic stimulation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400088535
Enrollment
Unknown
Registered
2024-08-20
Start date
2024-09-01
Completion date
Unknown
Last updated
2024-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post stroke cognitive impairment

Interventions

Sponsors

Shanghai Seventh People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Age = 18 years old 2. Meet the following characteristics 2.1 Clear stroke diagnosis: A stroke diagnosis supported by clinical or imaging evidence, including transient ischemic attacks and ischemic stroke. 2.2 The patient's chief complaint, informant's report, or experienced clinical physician's judgment of cognitive impairment after a stroke event, and neuropsychiatric evidence confirming the presence of functional impairment in one or more cognitive domains or evidence of cognitive decline compared to the past. 2.3 Temporal relationship between stroke and cognitive impairment: It occurs after the stroke event and lasts for 3-6 months. 3. Sign the informed consent form.

Exclusion criteria

Exclusion criteria: Visual and auditory defects may affect prediction and evaluation; Individuals with aphasia who struggle to communicate normally; 3. Training and evaluation that cannot maintain independent sitting for at least 0.5 hours and tolerate 1 hour; Unable to tolerate sound and light stimuli; 4. Use of drugs that alter the excitability of the brain white matter in the past three months (such as antiepileptic drugs, sedative hypnotic drugs, etc.); Patients diagnosed with mental illness, severe depression (with suicidal tendencies) or epilepsy, and those with a family history of mental illness or epilepsy; 6 serious heart, liver, kidney diseases or infectious diseases; Or the expected lifespan is less than 90 days; Have participated in or are currently undergoing drug or device clinical trials within the past 30 days; Pregnant or lactating women of childbearing age who have negative pregnancy tests but refuse to take effective contraceptive measures. 9. Diagnosed with other types of cognitive impairment in the past

Design outcomes

Primary

MeasureTime frame
Changes in cognitive function of patients before and after prediction;

Secondary

MeasureTime frame
Pre pre - and post synaptic remodeling;Pre emptive changes in the neural network of the anterior and posterior brain;Changes in tissue perfusion before and after intervention;Dizziness assessment;Assessment of photosensitive epilepsy;

Countries

China

Contacts

Public ContactFeng Wang

Shanghai Seventh People's Hospital

wangfengshutcm@163.com+86 138 1656 6556

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 27, 2026